RU2007107532A - METHOD FOR TREATING PRIMARY HEMOSTASIS DISORDERS IN PERSONS WITH METABOLIC SYNDROME - Google Patents

METHOD FOR TREATING PRIMARY HEMOSTASIS DISORDERS IN PERSONS WITH METABOLIC SYNDROME Download PDF

Info

Publication number
RU2007107532A
RU2007107532A RU2007107532/14A RU2007107532A RU2007107532A RU 2007107532 A RU2007107532 A RU 2007107532A RU 2007107532/14 A RU2007107532/14 A RU 2007107532/14A RU 2007107532 A RU2007107532 A RU 2007107532A RU 2007107532 A RU2007107532 A RU 2007107532A
Authority
RU
Russia
Prior art keywords
body weight
years old
metabolic syndrome
persons
primary hemostasis
Prior art date
Application number
RU2007107532/14A
Other languages
Russian (ru)
Other versions
RU2342137C2 (en
Inventor
Иль Николаевич Медведев (RU)
Илья Николаевич Медведев
Борис Дмитриевич Беспарточный (RU)
Борис Дмитриевич Беспарточный
Original Assignee
Иль Николаевич Медведев (RU)
Илья Николаевич Медведев
Борис Дмитриевич Беспарточный (RU)
Борис Дмитриевич Беспарточный
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иль Николаевич Медведев (RU), Илья Николаевич Медведев, Борис Дмитриевич Беспарточный (RU), Борис Дмитриевич Беспарточный filed Critical Иль Николаевич Медведев (RU)
Priority to RU2007107532/14A priority Critical patent/RU2342137C2/en
Publication of RU2007107532A publication Critical patent/RU2007107532A/en
Application granted granted Critical
Publication of RU2342137C2 publication Critical patent/RU2342137C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (1)

Способ лечения нарушений первичного гемостаза у лиц с метаболическим синдромом, включающий применение индивидуально подобранной гипокалорийной диеты, рассчитанной в ккал по формуле:A method for the treatment of primary hemostasis disorders in people with metabolic syndrome, including the use of an individually selected hypocaloric diet calculated in kcal according to the formula: для женщин: 18-30 лет - (0,0621 × масса тела, кг + 2,0357)×240;for women: 18-30 years old - (0.0621 × body weight, kg + 2.0357) × 240; 31-60 лет - (0,0342 × масса тела, кг + 3,5377)×240;31-60 years old - (0.0342 × body weight, kg + 3.5377) × 240; старше 60 лет (0,0377 × масса тела, кг + 2,7545)×240;over 60 years old (0.0377 × body weight, kg + 2.7545) × 240; для мужчин: 18-30 лет - (0,0630 × масса тела, кг + 2,8957)×240;for men: 18-30 years old - (0.0630 × body weight, kg + 2.8957) × 240; 31-60 лет - (0,0484 × масса тела, кг + 3,6534)×240;31-60 years old - (0.0484 × body weight, kg + 3.6534) × 240; старше 60 лет (0,0491 × масса тела, кг + 2,4587)×240,over 60 years old (0.0491 × body weight, kg + 2.4587) × 240, дилтиазем 60 мг 2 раза в сутки и спираприл 6,21 мг 1 раз утром.Diltiazem 60 mg 2 times a day and Spiralpril 6.21 mg 1 time in the morning.
RU2007107532/14A 2007-02-28 2007-02-28 Treatment method for primary hemostasia disorders in metabolic syndrome patients RU2342137C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2007107532/14A RU2342137C2 (en) 2007-02-28 2007-02-28 Treatment method for primary hemostasia disorders in metabolic syndrome patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007107532/14A RU2342137C2 (en) 2007-02-28 2007-02-28 Treatment method for primary hemostasia disorders in metabolic syndrome patients

Publications (2)

Publication Number Publication Date
RU2007107532A true RU2007107532A (en) 2008-09-10
RU2342137C2 RU2342137C2 (en) 2008-12-27

Family

ID=39866431

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007107532/14A RU2342137C2 (en) 2007-02-28 2007-02-28 Treatment method for primary hemostasia disorders in metabolic syndrome patients

Country Status (1)

Country Link
RU (1) RU2342137C2 (en)

Also Published As

Publication number Publication date
RU2342137C2 (en) 2008-12-27

Similar Documents

Publication Publication Date Title
EP2422819A3 (en) Compositions and their uses directed to Huntingtin
WO2006037031A3 (en) Formulations and methods for treatment of inflammatory diseases
WO2006067165A3 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
WO2006113802A3 (en) Device for administering electrode stimulation of back and abdominal muscles
WO2007143231A3 (en) Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
BRPI0519124A2 (en) compound, method for treating, preventing or ameliorating obesity and related diseases and / or symptoms thereof, pharmaceutical composition, compound use, and combination
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
IL195472A0 (en) Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
WO2010151755A3 (en) TREATMENT OF INFLAMMATORY DISEASES USING miR-124
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
UA105644C2 (en) Methods of treating pulmonary disorders with liposomal amikacin formulations
MXPA06012143A (en) Arylsulfonamides and uses related thereto.
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
NO20055187L (en) Procedures for the treatment and prevention of lower urinary tract symptoms
TNSN07474A1 (en) Dosage regimen for prasugrel
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
RU2007119067A (en) MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA
WO2011022633A3 (en) Method of threating cancer
RU2007107532A (en) METHOD FOR TREATING PRIMARY HEMOSTASIS DISORDERS IN PERSONS WITH METABOLIC SYNDROME
PL1732551T3 (en) Perhexilin for treating chronic heart failure
WO2007144889A3 (en) Treatment of neurofibromatosis
MX2009006670A (en) Pharmaceutical composition using aliskiren and avosentan.
RU2007113591A (en) METHOD FOR TREATING PLATELET DYSFUNCTIONS IN PERSONS AFFECTING A METABOLIC SYNDROME
RU2007107521A (en) METHOD FOR OPTIMIZING THROMBOCITARY FUNCTIONS IN PERSONS WITH METABOLIC SYNDROME
DE502006005837D1 (en) Medicaments and / or dietary supplements containing Nisylen, Cepa, Euphrasia, Belladonna and / or Mercurius solubilis

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110301